Canada Our Time to Lead Ongoing Globe and Mail series explores the
potential risks and rewards of genome mapping
Exposed: The DNA Dilemma in print and online at ourtimetolead.ca
TORONTO, Dec. 7, 2012 /CNW/ - On Saturday, December 8, 2012, The Globe
and Mail will introduce Exposed: The DNA Dilemma, a two week series exploring the potential of genome sequencing to
answer the questions: should you share your DNA? Should you give
scientists the opportunity to explore and decode your personal genetic
make-up? Theseries introduces commentary and insights shaped by scientists, medical
leaders and Canadians who have debated sharing their DNA or
participated in genome mapping. The Globe explores the opportunities
and risks of genome sequencing, including the disappointments of the
genetic revolution so far as well as the successes. Exposed: The DNA Dilemma is the latest theme to be explored by The Globe's editorial series,
Canada: Our Time to Lead (www.ourtimetolead.ca).
"Our Time to Lead continues to stimulate conversation and debate, and in
this series, The DNA Dilemma, we're asking Canadians to weigh in on the
risks and potential rewards of DNA mapping and how that might change
their future," said John Stackhouse, Editor-in-Chief of The Globe and
Mail. "We've brought this series to life through personal stories,
online debates and medical and scientific insight. Over the next two
weeks, we'll help Canadians understand the impact and opportunities of
sharing their DNA - for their benefit, and for that of the larger
good."
The Globe and Mail will present how Canada compares to global
genome-mapping giants like China. The Globe will also look at why
companies such as Visa and Google want your DNA, and give readers the
opportunity to weigh in on the debate of whether babies and kids should
be screened. Medical Reporter Carolyn Abraham explores genetic
discrimination - the danger of knowing too much about a person's DNA,
and making decisions based on the DNA knowledge. Abraham examines the
concerns of veering down this path, particularly by insurers and
employers who could benefit from knowing an individual's predisposition
toward any number of medical conditions, from vision loss to cardiac
arrest and cancer.
Exposed: The DNA Dilemma is supported by a number of interactive features and online debates at
ourtimetolead.ca, including:
-
Digital mosaic of influential experts and Canadians who are sharing
their DNA
-
Online polling to simply ask readers: Would you share your genetic code?
-
Video interviews with Canadians who have had their DNA sequenced
-
Online debate questions to determine where readers sit on key ethical
questions; and
-
An online card game that deals players a random set of genes and shows
readers the probable consequences of their genetic markers.
About The Globe and Mail
The Globe and Mail, through its newspaper, magazine, online and mobile
platforms, is Canada's foremost news media company. Each day, The Globe
leads the national discussion by engaging Canadians in its
award-winning coverage and analysis of news, politics, business and
lifestyle. The Globe and Mail, Canada's national newspaper, founded in
1844, Report on Business, Canada's most influential business magazine,
and globeandmail.com, the newspaper's online and mobile media hub,
reach a combined 6.0 million readers every month. The Globe has
received numerous journalism awards, including the international prize
for General Excellence in Journalism from the Online News Associations
in 2011, nine Michener Awards for Public Service Journalism, and more
National Newspaper Awards than any other newspaper in Canada. The Globe
and Mail is 85% owned by Woodbridge, the investment arm of the Thomson
family, and Bell Canada (15%).
SOURCE: Globe and Mail